Elon Musk says he was a 'fool' for funding OpenAI: report

Elon Musk reportedly told jurors he felt like a "fool" for funding OpenAI, underscoring his claim that the company shifted from a nonprofit mission to a for-profit model. He is seeking up to $150 billion in damages, along with leadership changes and a return to nonprofit structure, in a federal trial in Oakland. OpenAI denies wrongdoing and says Musk is trying to control the company and benefit his own AI venture, xAI.

Analysis

This reads less like a binary legal outcome for MSFT than a slow-burn governance overhang on the AI stack. The immediate market effect is reputational, but the second-order issue is that the case reinforces a premium for firms with cleaner commercialization pathways and tighter cap-table control, while raising the discount rate on “mission” narratives in frontier AI. That favors incumbents with distribution and capital discipline over venture-style AI assets that still rely on narrative rather than durable cash flow.

For MSFT, the bigger risk is not damages per se but discovery risk and narrative contamination around its OpenAI partnership. Even if the legal claim ultimately fails, months of headlines can keep a lid on multiple expansion in a stock that is increasingly valued on AI monetization optionality; the market tends to punish uncertainty more than quantified liability. A real catalyst would be any ruling that narrows OpenAI’s ability to maintain its current structure or forces changes in governance, because that could alter Microsoft’s access economics and bargaining leverage.

TSLA is only modestly affected directly, but the trade matters through Musk attention and capital allocation. The litigation keeps management bandwidth tied up and reinforces the market’s willingness to ascribe a governance discount to Musk-controlled optionality, which can show up as higher volatility premia across the complex. The contrarian view is that this may actually be net-positive for xAI over time if it accelerates investor differentiation between “platform AI” and “lab AI,” though that is a longer-dated story and not a near-term P&L driver.

Near term, the setup is about dispersion rather than index beta. The market is likely underpricing the chance that recurring trial headlines cap upside in MSFT relative to AI peers over the next 1-3 months, while TSLA probably absorbs only a small sentiment shock unless the case broadens into Musk credibility or board-governance issues more generally.

Key Decisions for Investors

• Short MSFT / long AMZN or GOOGL as a 1-3 month relative-value hedge: MSFT carries the most direct OpenAI governance overhang, while the pair reduces market beta and isolates AI commercialization dispersion.
• For event risk, buy 1-2 month MSFT put spreads funded against upside calls if held through trial milestones; skew is likely to remain elevated, and headline risk can compress multiple expansion even without fundamental damage.
• Keep TSLA exposure market-neutral rather than outright directional for the next 4-6 weeks; if needed, hedge with short-dated calls against a long core position because this is more a volatility event than a thesis breaker.
• If a court order or ruling appears likely to constrain OpenAI governance, add to AI infrastructure beneficiaries with cleaner monetization paths over 3-6 months; the market should rotate toward names where AI spend converts directly into revenue visibility.